BiotechTube
OraSure Technologies

OraSure Technologies

Bethlehem, United States· Est.
orasur.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $100M

Overview

OraSure Technologies' mission is to empower individuals and healthcare providers with rapid, accurate, and accessible diagnostic information. The company has achieved market leadership in oral fluid diagnostics, most notably with its FDA-approved OraQuick® tests for HIV and HCV, and its InteliSwab® COVID-19 test. Its strategy focuses on expanding its rapid test portfolio, growing its molecular collection business, and leveraging its platforms into new disease areas and geographic markets to drive sustainable growth beyond pandemic-related revenue.

Infectious DiseaseSubstance Abuse

Technology Platform

Proprietary oral fluid (saliva) immunoassay and specimen collection/stabilization platforms enabling rapid, instrument-free diagnostic tests and stable transport of samples for molecular lab analysis.

Funding History

2
Total raised:$100M
Debt$100M
IPOUndisclosed

Opportunities

Significant growth potential lies in the expansion of universal Hepatitis C screening using the OraQuick® HCV test and the sustained endemic market for COVID-19/flu self-testing.
The molecular collection business offers a stable, high-margin revenue stream as saliva-based testing gains adoption for a wider range of conditions beyond infectious diseases.

Risk Factors

The company faces a sharp and challenging revenue transition as COVID-19-related sales decline, coupled with intense pricing pressure in the rapid test market.
Regulatory hurdles and changes in healthcare reimbursement policies for its core tests pose additional material risks to financial performance.

Competitive Landscape

OraSure competes in segmented markets against large players like Abbott and Roche, as well as numerous low-cost manufacturers. Its primary defensibility stems from deep specialization in oral fluid diagnostics, strong brand recognition for OraQuick®, and proprietary, easy-to-use device designs that cater to decentralized testing needs.

More companies in Diagnostics & Precision Medicine →More companies in United States →